Leuprolide

OA: gold
View on PubMed
AI-generated summary by gemini-2.5-flash-lite, 2026-08-09

This paper reviews leuprolide's use for prostate cancer and other sex hormone-related conditions, detailing its indications, mechanism, contraindications, and monitoring for interprofessional team management.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Leuprolide is a medication used in the management and treatment of prostate cancer, endometriosis, uterine fibroids, precocious puberty, and other sex hormone-related conditions. It is in the GnRH agonist class of medications. This activity reviews the indications, mechanism of action, contraindications, monitoring protocols, and other vital factors pertinent for members of an interprofessional team managing the care of patients with prostate cancer and other sex hormone-related disorders.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

SciLite annotations

chemicals 2
leuprolide leuprolide

Source provenance

europepmc
last seen: 2026-09-02T07:05:44.937405+00:00
scilite
last seen: 2026-07-12T09:48:33.364277+00:00